Loss of nicotinic acetylcholine receptor subunits α4 and α7 in the cerebral cortex of Parkinson patients

Parkinsonism and Related Disorders

Volumn 9, Issue 5, 2003, Pages 243-246

  Burghaus, Lothar ^a   Schütz, Ulrich ^a   Krempel, Udo ^a   Lindstrom, Jon ^b   Schröder, Hannsjörg ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Human cerebral cortex; Nicotinic acetylcholine receptor; Parkinson's disease; Western blot

Indexed keywords

ISOPROTEIN; NICOTINIC RECEPTOR; PROTEIN SUBUNIT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOLECULAR BIOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 0038360749     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(03)00028-2     Document Type: Article

References (25)

1. Lange K.W., Wells F.R., Jenner P., Marsden C.D. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease. J Neurochem. 60:1993;197-203.
2. Rinne J.O., Myllykylä T., Lönnberg P., Marjamäki P. A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Brain Res. 547:1991;167-170.
3. Perry E.K., Morris C.M., Court J.A., Cheng A., Fairbairn A.F., McKeith I.G. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience. 64:1995;385.
4. 3H]-nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology. 38:1988;720-723.
5. Newhouse P.A., Potter A., Levin E.D. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Drugs Aging. 11:1997;206-228.
6. Quik M., Jeyarasasingam G. Nicotinic receptors and Parkinson's disease. Eur J Pharmacol. 393:2000;223-230.
7. Paterson D., Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol. 61:2000;75-111.
8. Burghaus L., Schütz U., Krempel U., de Vos R.A.I., Jansen Steur E.N.H., Wevers A., Lindstrom J., Schröder H. Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Mol Brain Res. 76:2000;385-388.
9. Banerjee C., Nyengaard J.R., Wevers A., de Vos R.A., Janser Steur E.N.H., Lindstrom J., Pilz K., Nowacki S., Bloch W., Schröder H. Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease - a stereological approach. Neurobiol Dis. 7:2000;666-672.
10. Guan Z.Z., Zhang X., Ravid R., Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem. 74:2000;237-243.
11. Martin-Ruiz C.M., Court J.A., Molnar A., Lee M., Gotti C., Mamalaki A., Tsouloufis T., Tzartos S., Ballard C., Perry R.H., Perry E.K. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J Neurochem. 73:1999;1635-1640.
12. Whiting P.J., Lindstrom J. Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J Neurosci. 8:1988;3395-3404.
13. Schoepfer R., Conroy W.G., Whiting P., Gore M., Lindstrom J. Brain α-bungarotoxin binding protein cDNAs and mAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron. 5:1990;35-48.
14. Peng X., Anand R., Whiting P., Lindstrom J. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol. 46:1994;523-530.
15. Del Toro E.D., Juiz J.M., Xiao P., Lindstrom J., Criado M. Immunocytochemical localization of the α7 subunit of the nicotinic acetylcholine receptor in the rat central nervous system. J Comp Neurol. 349:1994;325-342.
16. McLane K., Wu X., Lindstrom J., Conti-Tronconi B. Epitope mapping of polyclonal and monoclonal antibodies against two alpha bungarotoxin-binding subunits from neuronal nicotinic receptors. J Neuroimmunol. 38:1992;115-128.
17. Peng X., Katz M., Gerzanich V., Anand R., Lindstrom J. Human α7 acetylcholine receptor: cloning of the α7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional α7 homomers expressed in Xenopus oocytes. Mol Pharmacol. 45:1994;546-554.
18. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
19. Schröder H., Wevers A. Nicotinic acetylcholine receptors in Alzheimer's disease. Alzheimers Dis Rev. 3:1998;20-27.
20. Dubois B., Danze F., Pillon B. Cholinergic-dependent cognitive deficits in Parkinson's disease. Ann Neurol. 22:1987;26-30.
21. Lawrence A.D., Sahakian B.J. Alzheimer's disease, attention and the cholinergic system. Alzheimer Dis Assoc Disord. 9:(Suppl. 2):1995;43-49.
22. Perry E.K., Curtis M., Dick D.J. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 48:1985;413-421.
23. Aubert I., Araujo D.M., Cecyre D., Robitaille Y., Gauthier S., Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J Neurochem. 58:1992;529-541.
24. Durany N., Zochling R., Boissl K.W., Paulus W., Ransmayr G., Tatschner T., Danielczyk W., Jellinger K., Deckert J., Riederer P. Human post-mortem striatal alpha4 beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome. Neurosci Lett. 287:2000;109-112.
25. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry. 38:1995;22-33.